Belinda Termeer, Angel Investor

Belinda Termeer is the President, Co-Founder, and Board Member of the Termeer Institute, where she leads initiatives to advance innovation and leadership in life sciences. She also heads the Termeer family office and serves on boards including Harvard Medical School, MIT Museum, BIO Ventures for Global Health, and Massachusetts General Hospital, alongside advisory and board roles with several emerging biotech companies. In 2011, Belinda and her late husband, Henri Termeer, established the Henri and Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital Cancer Center, building on Henri’s legacy as CEO of Genzyme and advancing personalized medicine for rare diseases. As an angel investor, Belinda supports seed and early-stage companies in the life sciences. Her portfolio includes Artax Biopharma, PIC Therapeutics, and Amylyx Pharmaceuticals.